Evonik Rejects BASF's Improved $12.5 Billion Takeover Offer

Evonik Rejects BASF's Revised Takeover Offer

German specialty chemicals manufacturer Evonik Industries AG has rejected an improved takeover proposal from BASF SE valued at approximately €11.18 billion ($12.5 billion), declining to enter formal acquisition negotiations despite the higher offer.

The decision, announced on October 30, 2026, represents another setback for BASF's attempt to acquire one of Germany's largest specialty chemicals producers.

BASF increased its proposed acquisition price to €24 per share from an earlier offer of €22.15 per share, which Evonik rejected in September.

Despite the improvement, Evonik's executive board maintained that the company should continue pursuing its existing strategic direction as an independent business.

However, Evonik has left open the possibility of limited, confidential discussions with BASF to better understand the industrial rationale behind the proposed combination.

The rejection highlights differing views between the two German chemicals groups over consolidation, corporate valuation and the future structure of Europe's chemical manufacturing industry.

BASF believes a combination could strengthen competitiveness against international rivals, particularly producers in China and other regions.

Evonik, meanwhile, remains focused on developing its own business portfolio and has not agreed to formal takeover negotiations.

Key Highlights of the BASF–Evonik Takeover Proposal

The revised offer reflects BASF's continued interest in acquiring Evonik, although no definitive acquisition agreement has been reached.

BASF Raises Takeover Offer to €24 Per Share

BASF's revised proposal values Evonik at approximately €11.18 billion.

The offer of €24 per share represents an increase of €1.85 from the original €22.15 proposal.

This amounts to an improvement of approximately 8.35%.

The initial approach, valued at roughly €10.3 billion, was rejected in September.

The revised proposal was intended to encourage Evonik's management to begin formal discussions.

However, Evonik remained unconvinced that the terms and strategic rationale justified entering negotiations.

The company has not publicly disclosed a minimum valuation at which it would consider an acquisition.

Consequently, it remains uncertain whether a further increase in price would change the board's position.

Evonik Maintains Commitment to Independent Strategy

Evonik's executive board reiterated its intention to continue developing the company independently.

The board's position reflects its assessment of the company's strategic direction and long-term development opportunities.

Evonik operates across several specialty chemical markets, supplying products used in industrial manufacturing, consumer goods and other applications.

Its portfolio includes advanced materials, additives and specialty ingredients.

The company's strategy focuses on improving competitiveness, managing costs and developing businesses with attractive long-term prospects.

Remaining independent would allow Evonik to continue pursuing these priorities without integrating into BASF's wider operations.

However, independence also requires the company to address the structural challenges facing European chemical manufacturers.

Evonik Leaves Door Open for Limited Discussions

Although Evonik rejected formal takeover negotiations, it has indicated a willingness to engage in confidential discussions with BASF.

These discussions would be informational rather than negotiations over transaction terms.

Evonik wants BASF to explain its strategic reasoning and the potential benefits of combining the companies.

The distinction is important.

Agreeing to an informational exchange does not mean Evonik has accepted the proposal or committed to considering a formal acquisition.

It also does not guarantee that negotiations will begin later.

Nevertheless, the willingness to communicate leaves a limited channel open between the two companies.

Future developments will depend on whether BASF can address Evonik's concerns regarding the industrial rationale and financial terms.

BASF Expresses Surprise at Evonik's Decision

BASF responded by expressing surprise that Evonik was unwilling to begin negotiations.

The company considers its revised proposal attractive and believes the potential combination could create significant industrial benefits.

BASF also highlighted commitments relating to employees and manufacturing sites.

Management has argued that a merger could strengthen Germany's chemical industry against increasingly intense international competition.

However, BASF has also emphasised that it will not pursue an acquisition at any price.

The company must consider the financial interests of its own shareholders and the potential returns from a transaction.

This creates a limit on how much BASF may be prepared to increase its offer.

Markus Kamieth Sees Opportunity for German Chemicals Consolidation

BASF Chief Executive Officer Markus Kamieth has presented the potential acquisition as an opportunity to strengthen the German chemical industry's international competitiveness.

European manufacturers face competition from companies operating in regions with different energy costs, production economics and market conditions.

BASF believes a combination with Evonik could create a stronger industrial platform.

The proposed merger could potentially bring together complementary chemical manufacturing capabilities.

However, the companies have not announced a detailed integration plan or quantified transaction-specific synergies.

Kamieth has also stated that BASF would pursue an acquisition only if it created value for shareholders.

The company is therefore balancing its strategic interest in Evonik with financial discipline.

BASF Offers Employee and Manufacturing Site Commitments

Employment and manufacturing operations are important considerations in the proposed transaction.

BASF has offered commitments intended to address concerns about the future of Evonik's workforce and industrial facilities.

These include respecting existing employment protection agreements.

BASF has also indicated that compulsory redundancies would be ruled out until 2032 under its proposed commitments.

The company has emphasised the continued importance of Essen and North Rhine-Westphalia as industrial locations.

Such commitments can be significant in large European industrial mergers, where employment and regional economic interests often influence negotiations.

However, the commitments have not persuaded Evonik to begin formal talks.

The target company's board continues to prioritise its independent strategic direction.

Strategic Differences Remain a Major Obstacle

The proposed acquisition involves two companies with substantial but different positions in the chemical industry.

BASF is one of the world's largest diversified chemical manufacturers.

Its businesses cover basic chemicals, industrial materials, agricultural products and specialised chemical applications.

Evonik focuses more heavily on specialty chemical products and advanced materials.

Although the companies operate in related industries, combining them would involve integrating different business portfolios and operating structures.

Potential benefits could include procurement efficiencies, research capabilities and manufacturing coordination.

However, integration could also create operational complexity.

The companies have not reached an agreement on whether the potential benefits would justify the transaction.

Evonik's Specialty Chemicals Portfolio

Evonik supplies specialty chemical products used across several industrial and consumer markets.

Its operations include high-performance plastics, feed additives and ingredients used in coatings and household products.

Specialty chemicals are often designed to provide specific performance characteristics rather than simply serve as standard industrial inputs.

These products can support applications requiring advanced materials, formulation expertise or specialised manufacturing processes.

The company's business model relies on technical capabilities, customer relationships and product development.

Evonik's management considers these capabilities important to its long-term competitiveness.

The proposed BASF acquisition would bring these businesses into a much larger diversified chemical group.

However, Evonik has not agreed that such integration would be preferable to remaining independent.

BASF's Diversified Chemical Operations

BASF operates across a broad range of chemical and industrial markets.

Its product portfolio includes engineering plastics, superabsorbent polymers, vitamins and chemicals used in manufacturing.

The company also has significant agricultural and industrial businesses.

Its scale provides opportunities for integrated production, research and global distribution.

BASF has been implementing a strategic transformation focused on its core chemical operations and cost efficiency.

The company has also pursued portfolio changes, including divestments and plans involving its agricultural business.

An acquisition of Evonik could potentially expand its specialty chemicals exposure.

However, the transaction would also involve substantial acquisition expenditure and integration requirements.

German Chemical Industry Faces Global Competition

The proposed merger comes during a challenging period for European chemical manufacturers.

The industry faces structural pressures involving energy costs, international competition and changing industrial demand.

Chemical producers in China and other regions have expanded manufacturing capacity.

This has increased competitive pressure in several product categories.

European manufacturers must also manage regulatory requirements, energy infrastructure and environmental investment obligations.

These factors influence production costs and profitability.

BASF believes consolidation could help German chemical companies compete more effectively.

However, mergers are not the only potential response.

Companies can also pursue cost reductions, portfolio restructuring, technology investment and operational improvements independently.

Energy Costs Remain Important for European Producers

Chemical manufacturing is often energy-intensive.

Electricity, natural gas and other energy inputs can represent significant operating expenses.

European producers have faced periods of elevated energy prices and supply uncertainty.

These conditions can affect their competitiveness relative to manufacturers operating in lower-cost regions.

A merger could potentially create operational efficiencies, but it would not eliminate exposure to energy markets.

Both BASF and Evonik would continue to face global commodity and energy price movements.

The companies would therefore need to assess whether consolidation could deliver sufficient benefits to offset integration costs and financial commitments.

BASF Reports Stronger Third-Quarter Performance

BASF's latest quarterly results provide additional context for its acquisition ambitions.

The company reported third-quarter 2026 sales of approximately €16.4 billion.

The result exceeded analyst expectations by nearly 5%.

BASF also increased its full-year adjusted core earnings guidance for the second time during 2026.

The company now expects adjusted earnings before interest, taxes, depreciation and amortisation of €7.4 billion to €7.8 billion.

Its previous guidance range was €6.9 billion to €7.7 billion.

The improved outlook reflects stronger operating conditions in several businesses.

However, stronger earnings do not automatically justify a higher acquisition price.

BASF must still assess the potential financial returns and risks associated with buying Evonik.

BASF Continues Portfolio Restructuring

BASF has been pursuing strategic changes under its Winning Ways programme.

The strategy focuses on improving performance and strengthening the company's core operations.

The company has undertaken portfolio adjustments and cost reduction measures.

It has also outlined plans to list its agricultural business on the Frankfurt stock exchange by mid-2027.

These initiatives are intended to improve financial flexibility and business focus.

An acquisition of Evonik would represent a major expansion of BASF's portfolio transformation strategy.

However, the proposed transaction would also require substantial capital.

The company must therefore balance potential acquisition opportunities with existing investment and restructuring commitments.

RAG-Stiftung Holds a Major Stake in Evonik

RAG-Stiftung is Evonik's largest shareholder, holding approximately 44% of the company.

The foundation's ownership position makes it an important stakeholder in any potential takeover.

BASF has previously approached RAG-Stiftung regarding the possibility of acquiring Evonik.

However, the foundation has not publicly confirmed support for the revised proposal.

Its position could become significant if formal negotiations eventually begin.

A large shareholder's support can influence the prospects of a public takeover offer.

Nevertheless, applicable takeover rules and shareholder approval requirements would continue to govern any transaction.

Evonik Has Also Explored Acquisition Opportunities

Evonik has reportedly been exploring a potential acquisition of US specialty chemicals company Ashland.

The discussions have not resulted in a confirmed transaction.

The reported interest is significant because it suggests Evonik may view itself as a potential acquirer rather than solely an acquisition target.

Chief Executive Officer Christian Kullmann has previously indicated that consolidation in the chemical industry is likely.

He has also expressed the company's intention to participate actively in that process.

An acquisition strategy could allow Evonik to expand selected businesses while maintaining independence.

However, any potential transaction would require financial resources, strategic alignment and regulatory consideration.

Industry Consolidation Could Reshape European Chemicals

The proposed BASF–Evonik combination illustrates the consolidation pressures affecting the chemical industry.

Companies are reassessing business portfolios as competition intensifies and operating costs remain challenging.

Mergers can provide opportunities to combine manufacturing operations, research capabilities and distribution networks.

However, large transactions also involve financial and regulatory risks.

Potential competition concerns could arise where the merging companies have overlapping product markets.

Integration costs and organisational complexity may also affect expected benefits.

For European chemical producers, consolidation decisions therefore require careful assessment of industrial economics and shareholder value.

The rejection of BASF's proposal demonstrates that strategic interest alone is insufficient to secure a major acquisition.

Investors Assess Prospects for a Revised Proposal

Evonik's rejection creates uncertainty about the next stage of BASF's takeover effort.

BASF could continue seeking discussions, reconsider its valuation or redirect attention towards other acquisition opportunities.

However, the company has not announced a further increase in its offer.

Evonik has also not committed to entering formal negotiations.

Investors will monitor whether the informational discussions lead to any change in the companies' positions.

The share prices of both companies may remain sensitive to takeover-related developments.

However, the possibility of another proposal should not be treated as confirmation that a transaction will occur.

BASF Faces Limits on Acquisition Valuation

BASF's management has emphasised the importance of avoiding an excessive purchase price.

The company must consider whether the expected benefits of acquiring Evonik would justify the cost.

A higher offer could improve the proposal's attractiveness to Evonik shareholders.

However, it could also reduce the potential financial return for BASF investors.

The company would need to evaluate financing requirements, integration expenditure and potential operational synergies.

These considerations create a natural tension between the buyer's valuation discipline and the target company's expectations.

The revised €24-per-share offer has not resolved that difference.

What Happens Next in the BASF–Evonik Takeover Situation?

The immediate next step could involve confidential informational discussions between the two companies.

Evonik has indicated that it is willing to hear more about BASF's industrial rationale.

However, formal negotiations remain off the table.

Several possible outcomes remain open.

BASF could decide not to pursue the transaction further.

It could also reassess its proposal or continue seeking engagement with Evonik's management and shareholders.

Evonik may continue implementing its independent strategy and exploring other opportunities.

At present, no binding takeover agreement has been announced.

The future of the proposed combination remains uncertain.

Conclusion

Evonik Industries' rejection of BASF's improved €11.18 billion ($12.5 billion) takeover proposal represents a significant development in the European chemical industry's consolidation debate.

BASF increased its offer to €24 per share from €22.15, representing an improvement of approximately 8.35%.

Despite the higher valuation and commitments relating to employment and manufacturing sites, Evonik declined to begin formal acquisition negotiations.

The company remains committed to developing its business independently.

However, its willingness to engage in confidential informational discussions leaves open the possibility of further communication.

BASF continues to argue that a combination could strengthen German chemical manufacturers against global competition, while maintaining that it will not overpay.

The outcome will depend on whether the companies can reconcile their differences over valuation, strategic benefits and long-term industrial priorities.

For now, Evonik remains independent, and BASF's proposed acquisition has not progressed to a definitive agreement.